Creating Bioentrepreneurs: Enterprise Specialisation Launch
Thank you to all who attended and supported Creating Bioentrepreneurs: Enterprise Specialisation Launch, on Tuesday 17 July. The event was a great success, with a packed house at the Woodward Conference Centre taking part in invigorating discussion around the need and potential for greater innovation and commercialisation within the biomedical sector.
Panel discussion on "shaping the future workforce of the biomedical industry." From left: Andrew Wear (Victorian Government), Prof Fabienne Mackay (School of Biomedical Sciences), Dr Lynn Johnson Langer (Johns Hopkins University), Prof Andrew Cuthbertson (CSL Limited), Dr Glenn Begley (BioCurate).
Professor Fabienne Mackay (Head, School of Biomedical Sciences) and Associate Professor James Ziogas (Course Coordinator, Master of Biomedical Science) outlined the compelling case for the new Enterprise specialisation, part of the Master of Biomedical Science, which focuses on entrepreneurship and commercialisation within biomedical science. James then introduced international guest speaker Dr Lynn Johnson Langer (Johns Hopkins University, USA), who presented the Johns Hopkins Experience: a leading example of successful graduate biotech education and industry collaboration.
A lively and fascinating panel discussion followed after morning tea, with Lynn and other experts from industry, government and academia discussing "shaping the future workforce of the biomedical industry." Here are some insightful quotes from our panel, captured in the #UnimelbSBS Twitter feed:
- Learn the vocabulary of science and business. Commercialisation of science is critical. You're at a strong global disadvantage if you don't take up this opportunity. Dr Lynn Johnson Langer (Acting Associate Dean, Advanced Academic Programs, Johns Hopkins University)
- 16 years of industry have made two things apparent: 1) it is absolutely crucial to be part of a team. 2) flexibility is vital. Dr C. Glenn Begley (CEO, BioCurate)
- We need to rework how we think about PhDs. It's important to have a broader view of what a PhD is, so that students can make more informed decisions about where it can take them. Prof Fabienne Mackay (Head, School of Biomedical Sciences)
- We need to move beyond translational research to create a vibrant commercial job market. We need people who understand the commercialisation process and drug development pathways. Mr Andrew Wear (Director of Medical Technologies and Pharmaceuticals, Victorian Government)
- The Enterprise Specialisation combines entrepreneurship and a structured biomedical course and gives students an opportunity to diversify their skills in a formal and immensely rewarding way. Prof Andrew Cuthbertson (Chief Scientific Officer and R&D Director, CSL Limited)
A capacity audience at the Woodward Conference Centre.
During her visit, Lynn also made time to record a podcast with Dr Andi Horvath, on Eavesdrop on Experts. The full conversation, discussing getting biotech science out of the lab and into market, can be listened to here.
For more information about the Master of Biomedical Science, Enterprise Specialisation, please visit the Enterprise website.